SU2C, SandboxAQ collaborate to accelerate treatment innovation

She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research

Don’t try to convince Col. Susan Fondy that lymphedema doesn’t merit interest from medical researchers.

July 03, 2025

As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures

We recently had the privilege of contributing to a CBS Sunday Morning story on the ongoing crisis in the federal support for research in general and cancer research in particular.

July 03, 2025

Vol.51 No.26

By George J. Weiner and Elizabeth M. Jaffee

Scaling excellence: How City of Hope is transforming cancer care delivery

The landscape of cancer care in America faces critical challenges: geographic disparities in access, socioeconomic barriers to advanced treatments and the increasing complexity of precision medicine that outpaces individual providers’ ability to stay current. At City of Hope, we are addressing these systemic issues through a bold expansion that brings world-class cancer care and research closer to where patients live.

July 03, 2025

Vol.51 No.26

By Alan H. Bryce and Walter M. Stadler

In Brief

Besim Ogretmen named assistant vice president for research at MUSC

Besim Ogretmen was named assistant vice president for research in the Office of the Vice President for Research at the Medical University of South Carolina.

July 03, 2025

Vol.51 No.26

Clinical Roundup

More than half of cancer centers see AI as answer to operational challenges, report shows

LeanTaaS Inc. has conducted a national survey of nearly 200 nursing and operational leaders from community hospitals, academic medical centers, and private oncology practices.

July 03, 2025

Vol.51 No.26

Clinical Roundup

Scientists uncover new approach for targeting aggressive breast cancer

A recent study from cancer researchers at the University of Alabama at Birmingham and Georgia State University has identified a new therapeutic target in quadruple-negative breast cancer, or QNBC, one of the deadliest and most aggressive treatment-resistant forms of breast cancer.

July 03, 2025

Vol.51 No.26

SU2C, SandboxAQ collaborate to accelerate treatment innovation

YOU MAY BE INTERESTED IN

She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research

As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures

Scaling excellence: How City of Hope is transforming cancer care delivery

Besim Ogretmen named assistant vice president for research at MUSC

More than half of cancer centers see AI as answer to operational challenges, report shows

Scientists uncover new approach for targeting aggressive breast cancer

Renew today!

Subscriber content

Never miss an issue!

Login

SU2C, SandboxAQ collaborate to accelerate treatment innovation

YOU MAY BE INTERESTED IN

She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research

As cancer scientists, we must change how we engage with the public on the impact of NIH cutsWhat the scientific method obscures

Scaling excellence: How City of Hope is transforming cancer care delivery

Besim Ogretmen named assistant vice president for research at MUSC

More than half of cancer centers see AI as answer to operational challenges, report shows

Scientists uncover new approach for targeting aggressive breast cancer

Never miss an issue!

Login

As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures